Collegium Pharmaceutical (COLL) Net Cash Flow (2014 - 2026)
Collegium Pharmaceutical (COLL) posted quarterly Net Cash Flow of $37.4 million for Q1 2026, up 82.59% year-over-year from $20.5 million in Q1 2025, and down 53.92% quarter-over-quarter from $81.2 million in Q4 2025.
Collegium Pharmaceutical (COLL) Net Cash Flow (2014 - 2026) Analysis & Trends
Collegium Pharmaceutical's Net Cash Flow history runs 13 years deep, the most recent figure standing at $37.4 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 82.59% year-over-year to $37.4 million; the TTM figure through Mar 2026 stood at $172.5 million (up 253.21% YoY), while the FY2025 annual figure was $155.5 million, up 208.48% from the prior year.
- Net Cash Flow for Q1 2026 stood at $37.4 million, down from $81.2 million in the prior quarter.
- The five-year high for Net Cash Flow was $95.8 million in Q1 2023, with the low at -$108.9 million in Q3 2024.
- The 5-year median for Net Cash Flow is $16.0 million (2022), against an average of $5.9 million.
- Peak annual rise in Net Cash Flow reached 680.51% in 2022, while the deepest fall reached 1019.16% in 2022.
- Collegium Pharmaceutical's Net Cash Flow stood at $39.6 million in 2022, then sank by 149.5% to -$19.6 million in 2023, then jumped by 261.37% to $31.6 million in 2024, then surged by 156.79% to $81.2 million in 2025, then slumped by 53.92% to $37.4 million in 2026.
- Business Quant data shows COLL's Net Cash Flow at $37.4 million in Q1 2026, $81.2 million in Q4 2025, and $32.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | -81.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | -458.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -912.40 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 93.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Collegium Pharmaceutical | 894.62 Mn | 745.30 Mn | 110.29 Mn | -139.18 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -139.18 Mn |
| Jun 30, 2026 | -139.18 Mn |
| Mar 31, 2026 | 37.40 Mn |
| Mar 31, 2026 | 37.40 Mn |
| Dec 31, 2025 | 81.16 Mn |
| Dec 31, 2025 | 81.16 Mn |
| Sep 30, 2025 | 32.75 Mn |
| Sep 30, 2025 | 32.75 Mn |
| Jun 30, 2025 | 21.15 Mn |
| Jun 30, 2025 | 21.15 Mn |
| Mar 31, 2025 | 20.48 Mn |
| Mar 31, 2025 | 20.48 Mn |
| Dec 31, 2024 | 31.61 Mn |
| Dec 31, 2024 | 31.61 Mn |
| Sep 30, 2024 | -108.93 Mn |
| Sep 30, 2024 | -108.93 Mn |
| Jun 30, 2024 | -55.72 Mn |
| Jun 30, 2024 | -55.72 Mn |
| Mar 31, 2024 | -10.34 Mn |
| Mar 31, 2024 | -10.34 Mn |